Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure.
beta-blockade has a therapeutic role across the continuum of patients with heart failure (HF), with a demonstrated mortality benefit in stage II and III HF. Concerns regarding initiation and uptitration linger as patients with resting bradycardia, pulmonary, or vascular disease are often unnecessarily excluded from receiving therapy. We will review the risk data on beta-blockade and offer therapeutic strategies to help overcome residual barriers to the initiation and uptitration of this important therapy in patients with HF.
Tsai
Steve
S
University of Medicine and Dentistry of New Jersey--New Jersey Medical School, 185 South Orange Avenue, MSB I-536, Newark, NJ, 07103 USA.
Klapholz
Marc
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D006801:Humans; D010045:Outpatients; D017186:Titrimetry; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents